Efficacy and Safety of Alprostadil Prevent Contrast Induced Nephropathy

NCT01722513 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Kidney Diseases
Diabetes Mellitus
Acute Kidney Injury
Kidney Failure, Chronic
Renal Insufficiency

Interventions

DRUG: Alprostadil ﹠control

Sponsor

Shanghai 10th People's Hospital